Verona Pharma plc - American Depositary Shares (VRNA) Covered Calls
There are no covered calls available for Verona Pharma plc - American Depositary Shares.
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on develops and commercializes therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine (RPL554), is an inhaled, dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. The formulations of ensifentrine are under development for the treatment chronic obstructive pulmonary disease (COPD): nebulized ensifentrine is in Phase 2b clinical development for the maintenance treatment of COPD; and a dry powder inhaler and a pressurized metered-dose inhaler. The company also focuses on developing ensifentrine for the treatment of cystic fibrosis and asthma. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.
| Top 10 Open Interest For Oct 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | SLV covered calls | 1. | AIV covered calls | |
| 2. | IBIT covered calls | 7. | INTC covered calls | 2. | AREC covered calls | |
| 3. | GLD covered calls | 8. | AMZN covered calls | 3. | LAC covered calls | |
| 4. | SPY covered calls | 9. | QQQ covered calls | 4. | UAMY covered calls | |
| 5. | TSLA covered calls | 10. | IWM covered calls | 5. | HIVE covered calls | |
Want more examples? VREX Covered Calls | VRNS Covered Calls
